ID 525 - Kwas dokozaheksaenowy, Kwas eikozapentaenowy

PL: Kwas dokozaheksaenowy, Kwas eikozapentaenowy
EN: DHA+EPA - long chain omega 3 fatty acids
Pdf: eicosapentaenoic acid

Oświadczenie (2)

1. Charakterystyka żywności / składnika

The food constituent that is the subject of the health claims is long-chain n-3 polyunsaturated fatty acids (n-3 LCPUFAs), namely docosahexaenoic acid (DHA) in combination with eicosapentaenoic acid (EPA).
The n-3 LCPUFAs, EPA and DHA, are well recognised nutrients and are measurable in foods by established methods. They are well absorbed when consumed in the form of triglycerides. This evaluation applies to EPA and DHA from all sources with appropriate bioavailability in the specified amounts.
The Panel considers that the food constituent, DHA and EPA, which is the subject of the health claims, is sufficiently characterised.

2.7. Utrzymanie prawidłowego stanu komórek nabłonka przewodu pokarmowego i skóry (ID 525)

The claimed effect is “skin and digestive tract epithelial cells maintenance”. The Panel assumes that the target population is the general population.
The claimed effect is not sufficiently defined. The proposed wordings do not provide further clarification (“a healthy digestive system, gentle on the stomach”) or do not refer to a physiological function (“appearance of skin, healthy looking skin, a part of your daily skin care routine, helps maintain a good complexion”) as required by Regulation (EC) No 1924/2006. The clarifications provided by Member States include several physiological functions, and the references provided do not allow the identification of the specific function which is the target for the claim.
The Panel considers that the claimed effect is general and non-specific, and does not refer to any specific health claim as required by Regulation (EC) No 1924/2006.

Warunki i możliwe ograniczenia stosowania oświadczenia

Usual consumption as traditional foodstuff in a normal diet. 340mg total Omega 3 fatty acids daily.